Recall
FDAHealthSeptember 5, 2025

Endo USA, Inc. — Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91

⚠️ Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
September 5, 2025

Nationwide within the United States

What's affected?

Product
Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91
Lot code
550172301

Additional details

Lot #: 550172301, Exp. Date January 2026

What should I do?

Recommended action

Class III recall. Voluntary: Firm initiated Quantity affected: 1,041 cartons.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.